Regen BioPharma, Inc.
RGBP
$0.026
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -762.37% | 96.24% | -94.56% | -103.61% | -6.20% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -158.73% | 0.00% | -21.25% | 272.09% | 0.00% |
| Total Other Non-Cash Items | -- | -100.00% | -96.58% | 5,750.00% | -- |
| Change in Net Operating Assets | -276.83% | -121.92% | 929.23% | -5.26% | 45.83% |
| Cash from Operations | 44.66% | -52.41% | 55.41% | 13.73% | 17.53% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -45.58% | 56.38% | 244.50% | -- | -- |
| Total Debt Repaid | -- | -- | -- | 92.86% | 184.00% |
| Issuance of Common Stock | -- | -- | -- | -79.23% | -27.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -45.58% | 56.38% | -25.06% | -43.83% | -4.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -100.00% | 366.67% | 99.02% | -274.85% | 64.87% |